Cancer is one of the leading causes of death in most countries and its consequences result in huge economic, social and psychological burden. Breast cancer is the most frequently diagnosed cancer type and the leading cause of cancer death among females. In this book, we discussed gene expression and DNA abnormalities including methylation in breast cancer. A recent important topic, roles of miRNAs and their potential use in cancer therapy have been discussed in this cancer type as well. Bioinformatics is very important part of recent human genome developments and data mining and thus this topic has also been added for the readers. It is hoped that this book will contribute to development of novel diagnostic as well as therapeutic approaches...
The discovery of microRNAs (miRNA) as novel modulators of gene expression has resulted in a rapidly ...
Combined analyses of molecular data, such as DNA copy-number alteration, mRNA and protein expression...
Breast cancer is one of the world’s most prevalent cancer among women. Globally approximately 2.3 mi...
For many years breast cancer classification has been based on histology and immune-histochemistry. N...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...
Micro-RNAs (miRNAs) are small molecules that modulate the translation of target mRNA through binding...
Breast cancer is the most frequently diagnosed cancer among females. Gene expression profiling metho...
The advent of the microRNAs in the early 1990s has proven to be a tremendously significant developme...
Regardless of advances in detection and treatment, breast cancer affects about 1.5 million women all...
Breast cancer is the leading cause of death in women in North America. The etiology of breast cancer...
Expression of microRNAs (miRNAs) has been found to be deregulated in all human cancers, where they m...
Combined analyses of molecular data, such as DNA copy-number alteration, mRNA and protein expression...
Breast cancer, as a highly heterogeneous malignant tumor, is one of the primary causes of death amon...
MicroRNAs (miRNAs) are an emerging class of gene expression modulators with relevant roles in severa...
At present, the biology of breast cancer remains poorly understood. Currently, lymph node metastases...
The discovery of microRNAs (miRNA) as novel modulators of gene expression has resulted in a rapidly ...
Combined analyses of molecular data, such as DNA copy-number alteration, mRNA and protein expression...
Breast cancer is one of the world’s most prevalent cancer among women. Globally approximately 2.3 mi...
For many years breast cancer classification has been based on histology and immune-histochemistry. N...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...
Micro-RNAs (miRNAs) are small molecules that modulate the translation of target mRNA through binding...
Breast cancer is the most frequently diagnosed cancer among females. Gene expression profiling metho...
The advent of the microRNAs in the early 1990s has proven to be a tremendously significant developme...
Regardless of advances in detection and treatment, breast cancer affects about 1.5 million women all...
Breast cancer is the leading cause of death in women in North America. The etiology of breast cancer...
Expression of microRNAs (miRNAs) has been found to be deregulated in all human cancers, where they m...
Combined analyses of molecular data, such as DNA copy-number alteration, mRNA and protein expression...
Breast cancer, as a highly heterogeneous malignant tumor, is one of the primary causes of death amon...
MicroRNAs (miRNAs) are an emerging class of gene expression modulators with relevant roles in severa...
At present, the biology of breast cancer remains poorly understood. Currently, lymph node metastases...
The discovery of microRNAs (miRNA) as novel modulators of gene expression has resulted in a rapidly ...
Combined analyses of molecular data, such as DNA copy-number alteration, mRNA and protein expression...
Breast cancer is one of the world’s most prevalent cancer among women. Globally approximately 2.3 mi...